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Todeterminetheroleoftoll-likereceptors(TLRs)myeloiddiﬀerentiationfactor88(MyD88)dependentpathwayinthespinalcord
secondary injury, compression injurywas made at T8 segment of the spinal cord in adult male Sprague-Dawley rats. Shown by RT-
PCR, TLR4 mRNA in the spinal cord was quickly elevated after compression injury. Intramedullary injection of MyD88 inhibitory
peptide(MIP)resultedinsigniﬁcantimprovementinlocomotorfunctionrecoveryatvarioustimepointsaftersurgery.Meanwhile,
injury area, p38 phosphorylation, and proinﬂammation cytokines in the injured spinal cord were signiﬁcantly reduced in MIP-
treated animals, compared with control peptide (CP) group. These data suggest that TLRs MyD88-dependent pathway may play
an important role in the development of secondary spinal cord injury, and inhibition of this pathway at early time after primary
injury could eﬀectively protect cells from inﬂammation and apoptosis and therefore improve the functional recovery.
1.Introduction
Acute traumatic spinal cord injury (SCI) is an unexpected,
catastrophic event which causes various lifelong disabilities
of the patients. The consequences also result in grave
inﬂuences in a row to family members and society. However,
there are no fully restorative therapies for SCI up to now
[1–3]. The pathological sequelae following acute SCI are
divided into two phases: primary mechanical injury and
secondary injury [4–6]. Primary SCI is caused by direct
mechanical trauma, and it instigates a progressive wave of
secondary injury via activation of a series of pathophysio-
logical mechanisms including alterations in microvascular
perfusion, inﬂammation, lipid peroxidation, free radical
generation, apoptotic/necrotic cell death, and dysregulation
of ionic homeostasis [7–11]. These mechanisms caused the
destruction of axonal tracts that were left intact after the
initial trauma, which is the major impediment to functional
recoveryafterSCI.Ithasbeenprovedthatﬁberssparedasfew
as 5–10% in the spinal cord are suﬃcient to facilitate basic
locomotion recovery following SCI in rats [12]. Therefore,
how to protect the spared ﬁbers and reduce the secondary
injury has become the top priority for scientists working in
the research of SCI.
Inﬂammatoryresponsesareveryimportant,evencentral,
in the pathological process of the acute and chronic phases
of secondary injury. During the secondary injury phase,
the central nervous system (CNS) evokes both innate and
adaptive immunities [11, 13]. After primary SCI, resident
microglia, invaded macrophages and dendritic cells could
work as antigen presenting cells through toll-like receptors
(TLRs) signaling [14] at and around the injury site. At
least 12 TLRs have been identiﬁed in the mammals, and
they are involved in recognition of pathogen-associated
molecular patterns (PAMPs) and activation/regulation of
both innate and adaptive immunities [15, 16]. Moreover,
it was recently shown that some TLRs (e.g., TLR2, TLR4)
can be stimulated by endogenous molecules named danger-
associated molecular patterns (DAMPs) [1]. DAMPs could
be released from injury sites of the tissue [17, 18]. In
SCI, many DAMPs including heat-shock proteins (HSPs),
necrotic cells, ﬁbronectin and hyaluronic acid, heparan2 Evidence-Based Complementary and Alternative Medicine
sulphate, lung surfactant protein A, high-mobility group
box 1 and mRNA would be increased at sites of spinal
injury, as accumulated studies reported [19–26]. Meanwhile,
research with genetic deﬁcient mice has indicated that TLR2
or TLR4 deﬁciency impaired function recovery in SCI [27],
while research with TLR4 loss-of-function mutation mice
showed that TLR4 deﬁciency protected against focal cerebral
ischemia and axotomy-induced neruodegeneration [28].
The signaling pathways activated by TLRs are broadly
classiﬁed into MyD88-dependent and -independent path-
ways because MyD88 is the universal adapter protein
recruited by all TLRs except TLR3 [29, 30]. TLRs MyD88-
dependentpathwayactivatesnuclear-factor-κB(NF -κB)[31]
and subsequently results in the production of inﬂammatory
cytokines (e.g., TNF-α,I L - 1 β)[ 32–35], while MyD88-
independent pathway is related to transcriptional activation
of type I interferons [36–38] and also activates late phase
NF-κB via TAK which is shared by MyD88-dependent
pathway. However, the exact roles of these pathways in the
pathophysiology of SCI remain unclear.
NF-κB is essential for neurons survival against oxidative
stress and ischemic degeneration [39], but it also contributes
to inﬂammation and apoptosis after CNS injury [40, 41].
The diﬀerent phases of NF-κB may serve distinct role in
this balance. Therefore, we hypothesized that TLRs MyD88-
dependent pathway correlated with the development of
spinal cord secondary injury via inﬂammatory reaction. In
this study, at ﬁrst we detected TLR4 mRNA expression
by RT-PCR in the spinal cord at several time points after
compression SCI, then used inhibitory peptide to block
MyD88-dependent signaling at early time after SCI, evalu-
ated motor functional recovery by Basso-Beattie-Bresnahan
(BBB) score, beam-walking test, and foot print analysis,
and investigated histological damage, cell apoptosis, and
inﬂammatory reactions with immunohistochemistry (IHC)
and Western blotting assay. We found that inhibition of
MyD88-dependent pathway at early time could reduce the
inﬂammatory response, preserve more neurons, reduce the
lesion size in the spinal cord, and therefore promote motor
functional recovery from spinal cord compression injury.
2.MaterialsandMethods
2.1. Animals and Surgical Procedure. Male Sprague-Dawley
rats (200–220g) were purchased from Experimental Animal
Center of the Fourth Military Medical University. Rats were
housed in a 12/12h light/dark cycle room with standard
rodentfoodandwateravailableadlibitum.Eﬀortsweremade
to minimize animal discomfort and to sacriﬁce the fewest
animals. All experiments were done in accordance with the
guidelines established by the Animal Care Committee of
Fourth Military Medical University.
All the rats were anesthetized with an intraperitoneal
injection of pentobarbital sodium (50–60mg/kg), and then
the back region was shaved and aseptically prepared with
iodophor. A laminectomy was performed at the T8 level to
expose the cord underneath without disrupting the dura.
After the spinous processes of T7 and T9 were clamped to
stabilize the spine, the exposed dorsal surface of the cord was
subjected to compression as described before [42]. Brieﬂy, a
compression plate attached to a 20g copper rod was used.
The compression plate was lowered down ventrally at a rate
of 0.5mm/min. It reached the bottom 5min later and was
removed at a constant speed.
After compression injury, 24 rats were used for RT-PCR
assay to detect TLR4 mRNA expression at 0h, 3h, 24h,
72h, 7d, and 14d after injury. Another batch of rats was
used for MyD88 blockade observation (Table 1). Locomotor
functions were evaluated, and histological analyses were
performed on this batch of animals.
2.2. Reverse Transcription PCR (RT-PCR) for TLR4. TLR4
mRNA levels after SCI were detected by using RT-PCR.
After compression SCI as previously described, rats were
anesthetized and sacriﬁced at 0h, 3h, 24h, 72h, 7d, and
14d after compression injury (for every time point, n =
4). Total RNA was isolated from 10mm of thoracic spinal
cord tissue centered at the injury site. RNA was puriﬁed
using the Trizol reagent according to the manufacturer’s
instructions. In order to remove any traces of contaminating
DNA,RNAsamplesweretreatedusingtheRNase-freeDNase
I (TaKaRa, Co., Ltd. Dalian, China). One microgram of
total RNA was reverse transcribed into ﬁrst strand cDNA in
each 20μL reaction mixture, according to the manufacturer’s
instructions (TaKaRa, Co., Ltd. Dalian, China). Primers used
were as follows: TLR4, sense: 5 -GTTGGATTTTACGAA-
TTCCACCT-3 , and antisense: 5 -TGCTTCTTGTTCTTC-
CTCTGATG-3 ; the expected size was 646bp; β-actin, sense:
5 -GAGAGGGAAATCGTGCGTGAC-3 , and antisense: 5 -
CATCTGCTGGAAGGTGGACA-3 ; and the expected size
was 453bp.
PCR was performed according to the manufacturer’s
instructions. The PCR mixture (20μL) contained 10μmol
of each primer, 200μMd N T P s ,2 5 m MM g C l 2,2 μL 10x
PCR buﬀer, 1U Taq DNA polymerase (TaKaRa, Co., Ltd.
Dalian, China), and 10μM puriﬁed cDNA. Denaturing,
annealing and extension times were 30 seconds each, at 95,
57, and 72◦C, respectively. cDNA samples were ampliﬁed
for 40 cycles. The speciﬁc product was separated on a 2%
agarose gel (Biowest, Spain) and detected after staining with
ethidium bromide under UV illumination.
2.3. MyD88 Blockade Experiments. After compression injury
as described previously, rats were randomly divided into
two groups: MIP group and CP group. Each rat of MIP
group received intramedullary injection of 5μLM y D 8 8
inhibitor peptide (MIP, 100μmol/L, Imgenex, USA), and
each rat of CP group was given 5μL control peptide (CP,
100μmol/L, Imgenex, USA), dissolved in 0.01mol/L PBS,
immediately after compression injury at the injury site. The
peptides we used for inhibition and control contain a protein
transduction(PTD)sequence(DRQIKIWFQNRRMKWKK)
derived from antennapedia, and the CP consists of only the
PTD sequence, which renders the peptide cell permeability.
The injections were done at both sides of the dorsal vein at
a constant rate of 1μL/min at about 1mm below the spinal
cordsurface.Thenthemusclesandskinwereclosedinlayers,Evidence-Based Complementary and Alternative Medicine 3
Table 1: Animal assignment for MyD88 blockade experiments.
Total Histological analysis Western blot assay
0h 7d 14d 7d
CP 18 3 5 5 5
MIP 18 3 5 5 5
and every two rats were placed in one cage. Manual bladder
expression was performed at least twice per day until reﬂex
bladder emptying was established.
2.3.1. Histological Analysis. Animals were perfused via the
left cardio-ventricle with 100mL of physiological saline and
subsequently with 400mL of 4% paraformaldehyde in 0.1M
phosphate buﬀer (PB, PH = 7.4) at 7d and 14 d, respectively
(n = 5).Threecentimetersspinalcordwascarefullydissected
out with the injury site in the center and was immersed in
25%sucrosesolutionfor24–48hat4◦Cuntilitsank.Sagittal
sections were cut at 20μm in thickness with a cryostat and
thawed-mounted onto gelatinized slides. The sections were
kept at −20◦C until used.
For Haematoxylin &Eosin (H&E) staining, sectionswere
washed brieﬂy in distilled water, stained in haematoxylin
solution for 5min. After this, sections were washed in
running tap water for 5min and diﬀerentiated in 1% acid
alcoholfor30sec.Thensectionswerewashedintapwaterfor
1min, placed in eosin for 30sec, dehydrated through 70%,
80%, 90%, and 100% alcohol 2min each, clear in 2 changes
of xylene, 5min each, and mounted with xylene-based
mounting medium.
For IHC staining, the sections were rinsed in PBS 3 times
5min and blocked with 1% bovine serum albumin for 1h
to eliminate nonspeciﬁc staining and then incubated with
primary antibodies 16–24h at room temperature. Primary
antibodies were rabbit anti-Cleaved Caspase-3 (1:400, Cell
Signaling Technology, USA), rabbit anti-GFAP (1:4000,
Sigma, USA), mouse anti-NeuN (1:500, Sigma, USA),
and goat anti-IgG (1:400, Millipore, USA). Then sections
were rinsed with PBS 3 times, 5min for each time, and
incubated with the appropriate secondary antibody for 2h
at room temperature. Sections were examined on Olympus
BX 51 microscope (Olympus, Japan) or FV 1000 confocal
microscope (Olympus, Japan).
For cell counting, ﬁve sections were chosen for analysis
in each rat, namely, the section with central canal and two
adjacent sections on both sides. After pictures were taken,
images were opened in Adobe Photoshop 9.0 and stuck
together as a montage. Caspase-3-positive cells (with nucleus
indicated by Hoechest staining) were counted from 4 repre-
sented areas randomly chosen in the sections. NeuN-positive
cells within the ﬁrst and second 1000 μm distance to the
lesion border were counted. The mean values of the ﬁve
sections in each rat were used for statistical analysis. For
lesion area measurement, GFAP staining images were taken
as mentioned previously. The boundary of the injured area
was outlined according to the diﬀerences between normal
tissue and necrotic tissue or cavity. The pixels of the outlined
areawerecalculatedandthenconvertedintothesizeofinjury
by using Adobe Photoshop 9.0 software.
2.3.2. Western Blot Assay. At 7d after compression SCI, ani-
mals were deeply anesthetized and sacriﬁced (n = 5). One-
centimeter long spinal cord tissues, 5mm rostral and 5mm
cordal to the injury site, were removed rapidly and stored
in liquid nitrogen and then processed for extraction of pro-
tein. Brieﬂy, tissue samples were homogenized with 0.5mL
of ice-cold lysis buﬀer (20mM Tris-HCl, pH 7.5, 1mM
EDTA, 5mM MgCl2,1m MD T T ,2 0μg/mL aprotinin, 1mM
PMSF, and 2mM sodium orthovanadate). The homogenates
were centrifuged at 13,000rpm for 10min at 4◦Ca n d
supernatant were removed. The protein concentration was
determined using Bradford method, a detergent-compatible
protein assay with a bovine serum albumin as standard.
Samples were boiled at 100◦C for 10min and then were
electrophoresed on 10–15% SDS-PAGE and transferred onto
a nitrocellulose membrane (Millipore, Bedford, MA, USA).
The ﬁlter membranes were blocked with 5% nonfat milk
for 1.5h at room temperature and incubated with the pri-
mary antibody (phospho-p38 MAPK 1:1000, Cell Signaling
Technology, MA, USA; caspase-3, 1:1000, Cell Signaling
Technology, MA, USA; TNF-α 1:500, Santa, CA, USA; IL-
1β, 1:1000, gifted by Professor Beifen Shen, Department
of Molecular Immunology, Beijing, China) 16–24h at 4◦C.
Then the membrane was washed with TBST buﬀer and
incubated with the secondary antibody conjugated with
horseradish peroxidase (1:8000; Jackson ImmunoResearch,
USA) for 1h at room temperature and visualized in ECL
solution. The density of speciﬁc bands was measured with
Image J (NIH, USA) software.
2.3.3. BBB Score. BBB scales were used to detect the recovery
of the motor function every day from 0d to 14d after injury.
Each rat was placed in an 80 × 130 × 30cm open ﬁeld and
run for 4 minutes and scaled from 0 to 21 point according to
the guidelines [43].
2.3.4. Beam-Walking Tests. Beam-walking tests were used to
detect the distance from the rump to the plane to reﬂect the
recovery of the motor function at 7d and 14d after injury.
T h ea p p a r a t u su s e df o rb e h a v i o r a la n a l y s i sb e a mi s1 2 0c m
long and 12cm wide and supported by a 70cm framework.
We set up a video camera and recorded the animal’s behavior
walking from one end to the other end of the beam. Then we
d i dvi d e of r a m ee x t r a c t i o na n ds e l e c t e d5r e p r e s e n t e df r a m e s
tomeasurerumpheightbyusingImagetool2.0(UTHSCSA)
software.
2.3.5. Footprint Analysis. Footprint analysis was conducted
at 7d and 14d after injury. A piece of white paper (15 ×
89cm2) was put on the track and both of the hindlimbs
plantar surfaces were colored blue and dorsal surfaces red
[44]. Then the rats were allowed to walk from one end
of the track to the other end. When foot dorsal surface
touched the track, the white paper would be printed with
red color, while when foot plantar touched the track, blue4 Evidence-Based Complementary and Alternative Medicine
color would be left on the white paper. Then the whole
paper with prints was scanned for analysis. Using Adobe
Photoshop 9.0 software, the percentage of red pixels deﬁned
as red/(blue + red) × 100% was calculated to reﬂect the
condition of toe dragging. Stride length (distance between
thecentersofipsilateraladjacentfootprints)andstridewidth
(perpendicular distance between the centers of left and right
hind limbs) were measured, and the average of ﬁve steps
in each case was used for statistical comparison. Because
only when injured rats walk well with plantar step, stride
lengthandwidthcouldbeclearenoughtobemeasured,these
parameters were taken only at 14d after injury.
2.4. Statistical Analysis. All data were presented as mean ±
standard deviation. The statistical signiﬁcance of diﬀerences
between groups was determined by one-way ANOVA fol-
lowed by Tukey test. The statistical program OriginPro 7.0
for windows was used for statistic analysis. Signiﬁcant levels
were set at P<0.05 or P<0.01.
3. Results
3.1. Expression of TLR4 mRNA after Compression SCI. RNA
extracted from spinal cord tissue after SCI at diﬀerent
times revealed time-related changes of TLR4 mRNA expres-
sion.TLR4 mRNA were dramatically increased at 24h after
SCI, with peak expression evident by 72h after injury, and it
was lowered to normal level at 14 d after injury (Figure 1).
3.2. Injury Area of Primary Injury. HE staining showed that
therewasnosigniﬁcantdiﬀerenceininjuryareaimmediately
after compression injury between the two groups. In CP
group, injury area was 0.8127 ± 0.05905mm2, and in MIP
group, it was 0.8206 ± 0.07541mm2 (Figure 2(c), P =
0.88723).
3.3. Inﬂammatory Cytokines and p38 MAPK Activation.
Western blot assay showed that inﬂammatory factors were
reduced by MIP treatment at 7d after compression injury
in the spinal cord. In MIP group, TNF-α was dramatically
decreased, compared with that in CP group (Figure 3(a),
P<0.05). And IL-1β in CP group was about twofolds of that
in MIP group (Figure 3(b), P<0.05). Phospho-p38 MAPK,
which is associated with TLRs MyD88-dependent pathway,
was also reduced after given MIP (Figure 3(c), P<0.05).
3.4. Cell Apoptosis and Injury Areas. Western blot analysis
was also performed to detect total caspase-3 (Figure 4(a)),
a marker for the apoptosis. The result showed that in MIP
group caspase-3 was dramatically decreased, compared with
which in CP group (Figure 4(b)). To conﬁrm the result,
caspase-3 IHC was done on the spinal cord sections at 7 d
after surgery (Figures 4(c) and 4(d)). Cell counting showed
by randomly choosing 4 represented areas that the number
of caspase-3 positive cells was signiﬁcantly decreased in
MIP group (139.1 ± 29.8) compared with that in CP group
(192.0 ±41.0) (Figure 4(e)).
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Figure 1: Semiquantitive analysis of TLR4 mRNA expression at
each time point after spinal cord injury by RT-PCR. Levels of TLR4
expression were presented as the ratio of the area integral values
under absorption curve of TLR4 with the area integral values of β-
actin. ∗∗Compared with the control group P<0.01; ##compared
with the previous group P<0.01.
Five sections of each group were used to do the NeuN
IHC staining to detect the number of preserved neurons
at 7d and 14d after injury, pictured by Olympus BX51
(Figure 5). NeuN-positive cells in 2000μm beside injury
area at the two end stumps were counted. At 7d after
injury, the result showed that there were more preserved
neurons in MIP group in the ﬁrst (234.8 ±49.2) and second
(343.0 ± 60.3) 1,000μm compared with CP group 191.6 ±
47.3 and 244.4 ± 84.2r e s p e c t i v e l y( P<0.05). At 14d after
injury, the results showed that MIP group had more neurons
(296.9 ± 64.8) than that of CP group (224.8 ± 17.9) in the
ﬁrst 1,000μm area (Figures 5(a1,b 1,A 1,B 1)( P<0.05).
While in the next 1,000μm area, there was no signiﬁcant
diﬀerence between the two groups (Figure 5(a2,b 2,A 2,B 2)
(P = 0.77719).
We used GFAP, a marker of the astrocyte, to show the
injury area at 7d and 14d (Figure 6(a) and 6(b)) after injury.
Statistics (Figure 6(c)) showed that there was a signiﬁcant
diﬀerence between the two groups in size of the lesion area.
MIP group got a smaller injury area at 7d (1.9 ± 0.6mm 2)
and 14d (1.4 ± 0.5mm 2) compared with that of CP group
3.4 ± 1.3mm 2 (P<0.05) 2.8 ± 0.6mm 2 (P<0.01), res-
pectively.
3.5. Locomotor Recovery. During the whole process, three
tests including BBB score, beam-walking test, and footprint
analysis were performed to compare the recovery of the
m o t o rf u n c t i o ni nd i ﬀerent treatments after SCI.
3.5.1. BBB Score. BBB test was performed every day after
injury.Results(Figure 7)showedthattherewasnodiﬀerenceEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Injury area of primary injury. The boundary of injury area was dot-lined in CP (a) and MIP (b) group. The cross indicated the
epicenter of the lesion. (c) is the histogram of the injury area in CP and MIP groups. There was no signiﬁcant diﬀerence between the two
groups in primary injury (P = 0.88723). Scale bar = 500μm. (d) IgG immunoreactivity in the spinal cord immediately after injury. Scale
bar = 200μm.
in the ﬁrst 3 days, while at the 4d after injury, the rats in
MIP group had better hindlimbs motor function recovery
than those in CP group. At 7d, rats in MIP group got an
average score of 15.2±4.6, which meant that those rats could
support their body weight by the hindlimbs and sometimes
walk coordinately. While CP group scored 6.3 ± 0.5, which
meant that the rats could only move two or three joints
of the hindlimbs extensively. At 14d, rats in MIP group
got an average score of 20.0 ± 1.0, which meant that the
rats walked coordinately with tail consistently up and had
no toe dragging. In CP group rats scored 14.5 ± 1.3( P<
0.05), Which meant the rats could support its weight by the
hindlimbs and walk coordinately with the tail down at this
time.
3.5.2. Beam-Walking Test. Beam-walking test was done to
detect the rump height which means the vertical distance
from base end of the rat tail to the surface of the beam.
This distance reﬂects the ability of the rat hindlimbs to
support its body weight. At 7 d and 14 d after injury there6 Evidence-Based Complementary and Alternative Medicine
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Figure3:Westernblotanalysisforproinﬂammatorycytokinesandphospho-p38MAPkinase.TNF-α,IL-1β,andP-p38MAPkinaseproteins
in the spinal cord were detected at 7 d after compression SCI in both MIP- and CP-treated groups. Levels of TNF-α (a), IL-1β (b), and P-
p38 MAP kinase (c) were signiﬁcantly decreased in MIP group, respectively, compared with CP group. Levels of proteins expression were
presented as the ratio of the band area integral values under absorption curve of each protein with the area integral value s of β-actin. The
quantiﬁed data are represented 4 animals per group (∗P<0.05).
were signiﬁcant diﬀerences in rump height between the two
groups (Figure 8). The height was 12.0 ± 4.7mm in MIP
group and 4.6 ± 1.2m mi nC Pg r o u pa t7d( P<0.05). At
14 d after injury, the height was 14.2±4.3mminMIPgroup
and 7.7 ± 3.5mminCPgroup(P<0.05).
3.5.3. Footprint Analysis. Three parameters including hind-
limbsstridelength,stridewidth,andtheratiooftoedragging
were taken from the footprint analysis (Figure 9(a)). These
measurements imply the gait recovery of the rats from SCI.
Figure 9(b) showed that at 7d after injury, the percentage
of red color pixels in MIP group was 25.8 ± 22.8%, and
in CP group it was 86.4 ± 7.3% (P<0.01); at 14d, the
percentage was 10.2±14.3% in MIP group and 48.8±11.3%
inCPgroup(P<0.05).Stridelengthandwidth(Figure 9(c))
measured at 14d after injury indicated signiﬁcant diﬀerences
between MIP and CP treatments. Compared with CP group,
MIP group had a bigger stride length (143.7±13.3mm) and
smaller stride width (38.1 ± 3.9mm) than that of CP group
(105.7 ±11.5mm, 68.1 ±10.3mm; P<0.05).
4. Discussion
Although whether endogenous ligands really trigger TLRs
signals without pathogen is debatable [45], many studies
have documented that TLRs responded to the host antigens
as well as bacteria [32, 46, 47]. These DAMPs combine to
TLRs to induce MyD88-dependent pathway to produce
proinﬂammatory cytokines [15, 16, 22, 48]. Our previ-
ous study in vitro also showed homologous IgG induced
microglia TLR4 expression and the TNF-α production
upregulated [49].
In the injured area of the spinal cord, the blood-spinal
cord barrier was destroyed by the primary injury, serum
proteins were extravasated easily into the parenchyma of
the spinal cord, as indicated by the IgG immunoreactivity,
tissue disruption would produce suﬃcient debris, and injury
may lead heat shock protein release from damaged neurons
and serve as DAMP as well, all of which may activate TLRs
signaling. In the present study, pathogen infection may not
be excluded but was minimized by keeping dura intact and
sterile manipulation. There was great amount of cell debris
caused by compression in the local spinal cord, and serum
proteins could easily enter to spinal parenchyma since the
local blood-spinal barrier was seriously damaged. All these
debris and serum proteins could serve as DAMP to bind and
activateTLRsinmicrogliaandothercellsaroundthewound.
As one of the well-studied TLRs that could be triggered
by endogenous DAMP, TLR4 has been documented to be
involved in a vicious cycle which mediates neurodegenera-
tion [50]. The other TLRs might also play roles in spinal
cordinjury-inducedinnateimmunereactivities;nevertheless
alteration of TLR4 expression may reﬂect TLRs responses
to DAMP in the present study. In our experiment, TLR4
mRNA was upregulated 3h after compression injury, peaked
between 24h and 72h after injury, and then came back
to the baseline at 14d (Figure 1), according to RT-PCREvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Total apoptosis at 7 d after injury. Western blotting (a) showed that, compared with CP group, caspase-3 in the spinal cord
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∗P<0.05. Immunohistochemistry for caspase-3 (green) and Hoechst 33342 (blue) counterstaining showed more apoptotic cells in CP
group (c) than that in MIP group (d) regardless of cell types, and (f) was the higher magniﬁcation of the square in (c) showing that caspase-
3 immunoreactive product appears in cytoplasm of the cells. The diagram (e) showed number of caspase-3 positive cells counted from 4
represented areas randomly chosen in the sections, and the number of apoptotic cells in MIP group was signiﬁcantly decreased, compared
with CP group (∗P<0.05).
detection. These data indicated that TLR4 responded to the
SCI quickly, and its expression was increased at early period
post injury. With this sterile SCI compression model, we also
revealed by immunoﬂuorescent staining that TLR4 protein
was mainly expressed in microglial cells in the injured area
of spinal cord (data not shown), indicating that the immune
response associated with TLR4 in the early stage was born
by microglial cells, which was the same result as Kigerl
et al. reported [27]. According to the report, most TLRs
were expressed twofolds more than sham injury controls
as early as one day after spinal cord injury. Then two
pathways of TLRs signaling would be activated as the DAMP
combined with them. At early phase of TLRs activation,
MyD88-dependent pathway may exert its inﬂammatory role
dominantly via NF-κB[ 31, 34].
After TLRs MyD88-dependent pathway was activated, it
will mediate the expression of proinﬂammatory genes and
leukocyte recruitment after CNS injury [51]. The present
study obtained the similar results from the compression SCI
in the rats. SCI caused IL-1β and TNF-α protein increased in
the spinal cord tissue, as shown by Western blotting assay.
MyD88 is a common molecule shared by most TLRs
(except TLR3) to activate NF-κB, resulting in the production
of large amounts of cytokines, including IL-1 and TNF-α
[52, 53]. The levels of IL-1β increase rapidly after traumatic
SCI [54–56]. TNF-α expression at both mRNA and protein
levels is also an immediate event after SCI [57, 58]. TNF-
α has been regarded as a key inﬂammatory regulator
that can induce further cytokine production, inﬂammation,
gliosis, demyelination, blood-brain-barrier damage, and cell
adhesion [59]. Sharma et al. reported that TNF-α antiserum
could alleviate the microvascular permeability disturbances,
cell damage, and edema in the spinal cord trauma in the rat
[60]. Nesic et al. reported that given IL-1 receptor antagonist8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: NeuN-positive cells in the spinal cord at 7d and 14d post injury. (a) and (b) are the representative pictures of NeuN
immunohistochemical staining in CP group and MIP group, respectively, at 14 d. The areas of a1 and b1, are the ﬁrst 1000μmf r o mt h e
lesionborderindicatedbyinitiatingappearanceofNeuNpositivecells,whilea2 andb2 aresecond1000μmadjac e ntt oa 1 andb1 respectively;
and A1,A 2,B 1, and B2, are the magniﬁcations of a1,a 2,b 1, and b2 respectively. (c) As compared to the CP group, the number of neurons is
signiﬁcantly higher in the MIP group in the ﬁrst 1000μm and the second 1000μm at 7d after injury (∗P<0.05), and at 14d there was an
obvious diﬀerence between CP and MIP groups in the ﬁrst 1000μm while there was no diﬀerence between these two groups in the second
1000μm.
at the site of injury could dramatically reduce the contusion-
induced apoptosis and caspase-3 activity in the model of
contused spinal cord injury [61].
In the context of proinﬂammatory cytokines production,
cell apoptosis developed in the adjacent area to the injury
site, indicated by caspase-3 elevation in the present study.
These ﬁndings are identical to the previous report by Pais
et al. [62] who demonstrated in vitro that necrotic neurons
could activate cultured microglia to produce proinﬂamma-
tory cytokines and thus induced apoptosis of hippocampal
neurons. Therefore, inﬂammation at the early stage exacer-
bates the disruption at the injured tissue by enhancement of
cell lost. Here we documented that traumatic injury to the
spinalcorditselfleadstotheearlyinﬂammationbytriggering
TLRs MyD88-dependent pathway.
The peptides we used for inhibition and control contain
a protein transduction (PTD) sequence (DRQIKIWFQNR-
RMKWKK) derived from antennapedia, and the CP consists
of only the PTD sequence, which renders the peptide cell
permeability. In the present study, these peptides were given
immediately after the compression injury was performed.
Although the eﬀective duration of the MIP was not deter-
mined in our study, it may start approximately 24h after
administration as in vitro study MIP need, to be incubated
with cells 24h ahead of intervention. The blockade period
could be partially overlapped with the main part of the
upregulated TLR4 expression period indicated by RT-PCR
data (Figure 1), especially to the early stage of the TLR4
MyD88 signals.
In our experiment, inhibition of MyD88-dependent
pathway with MIP signiﬁcantly lowered the levels of TNF-α
and IL-1β, and MIP treatment also inhibited the p38 MAPK
activation in the injured spinal cord. Namely, blockade of
MyD88signal inhibited NF-κB pathway and thereforedown-
regulated the production of proinﬂammatory cytokines in
the spinal tissue.
Meanwhile, cell apoptosis was reduced signiﬁcantly by
MIP treatment, indicated by caspase-3 expression. Cell
counting for NeuN-positive cells also formed that more
neurons survived in the MIP-treated group after SCI. These
data are consistent with previous report by Liebermann and
Hoﬀman that MyD88 mediates negative growth control,
including growth suppression and apoptosis [63].
Amelioration of apoptosis resulted in more cells survival;
at least more neurons were conserved, according to the
NeuN-positive cell counting in the present study. As it well
known, spared axons are pivotal for the functional recovery;
more neurons survival means that more axons in the spinal
cord are spared thus to enhance the function recovery.
The behavioral tests indicated clearly the improvement of
locomotor recovery in the rats treated with MIP, compared
with the CP-treated group. The obvious improvement was
seenfromthe4thdayafterSCItilltheendofourobservation
(14d post injury). These data imply the protective eﬀect ofEvidence-Based Complementary and Alternative Medicine 9
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Figure 6: GFAP immunohistochemical staining in the spinal cord section at 7d and 14d after injury. (a) and (b) represent pictures of
GFAP-stained sections of spinal cord in CP and MIP groups at 14d after injury, respectively. The boundary of the lesion area was dot-lined,
according to the GFAP immunoreactive product. The cross indicates the epicenter of the lesion. (c) is the histogram of the lesion area in CP
and MIP groups. There was a signiﬁcant diﬀerence between the two groups at 7d (∗P<0.05) and 14d after injury (∗∗P<0.01). Scale bar =
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Figure 7: The statistical analysis of the BBB score at diﬀerent time
points between the CP and MIP group. Compared with the CP
group, the BBB scores were signiﬁcantly improved in MIP group
at the fourth day after injury till the end of observation (14d)
(∗P<0.05).
blockade of MyD88-dependent signaling pathway at early
time in our experimental system.
We also found injury area smaller in the MIP group than
that in the control group. These ﬁndings imply that lowered
inﬂammation could preserve more cells including neurons
and thus may contribute to less secondary injury and better
behavioral function after SCI. Therefore, it would be protec-
tive to block TLRs MyD88-dependent pathway which maybe
play an important role in the development of secondary
spinal cord injury.
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Figure 8: The rump height measured through beam-walking test
in the CP and MIP groups. The body supporting ability recovered
slightly with time, indicated by the rump height elevating within
each group. Compared with the CP group, the rump height was
signiﬁcantlyelevatedinMIPgroupat7dand14dafterinjury(∗P<
0.05).
Proinﬂammatory factors of production cells may have
totally reverse action depending on when the cells were
activated and where they migrated [14]. Activated microglial
cells can secret lots of products that have harmful eﬀects on
adjacent neurons, while it can also produce some beneﬁcial
factors such as BDNF, NT-3, and TGF-β [64–67]. However,
some of these neurotrophic factors have been shown to
induce apoptosis of oligodendrocytes or neurons, sometimes10 Evidence-Based Complementary and Alternative Medicine
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Figure 9: Footprint analysis at 7d and 14d after injury. (a) Foot prints of red and blue traces. Arrows point to the direction of walking. CP
7d: there was only toe dragging, but no plantar stepping appeared. MIP 7d: plantar prints appeared. CP 14d: plantar prints were frequent
and coordinated while toe dragging was also seen. MIP 14d: the animal resumed almost normal walking. Scale bar = 3cm. (b) Percentage
of the toe dragging was signiﬁcantly reduced in MIP group, compared with CP group at 7d, 10 d, and 14d (∗∗P<0.01). (c) Stride length
at 14d was signiﬁcantly increased in MIP group in comparison to CP group (∗P<0.05); meanwhile the stride width was decreased in MIP
group compared with CP group (∗P<0.05).
during developmental regulation of neuronal proliferation,
sometimes in the injured adult organism [68]. Up to now,
the question of two-edge sword is unsolved. It is generally
accepted that suppression or inhibition of CNS macrophages
at the early time is neuroprotective after SCI [69–73],
though some authors hold that macrophages are beneﬁcial
to the recovery of SCI due to their anti-inﬂammation
role [74, 75]. The latter point of view maybe result from
the reduced accumulation of proinﬂammatory cytokines,
neurotoxins, and proteases, all of which can be released by
CNS macrophages [76–78].
Since the inﬂammation could be triggered by tissue
disruption via TLRs activated by endogenous DAMPs, roles
of TLRs in SCI have been studied extensively with many
technologies. Using genetic knockout mice, studies showed
the alteration in the CNS repair caused by TLR2, TLR4
deﬁciency [27], which is convinced and complete. However,
to some extent, it is diﬀerent with our results. The reasons
may lie in discrepancy of animal models, detailed experi-
mental systems, and the time window of proinﬂammatory
factors that aﬀect the SCI process. Therefore, speciﬁc antag-
onist/inhibitor of MyD88-dependent pathway at speciﬁcEvidence-Based Complementary and Alternative Medicine 11
phase only may target the harmful eﬀects, protect the spared
tissue after SCI regardless of the cell types, and promote
the recovery through inhibition of inﬂammation and cell
apoptosis.
It is interesting that stimulated astrocytes with TLRs
ligands could inhibit their ability to uptake excess glutamate
[79, 80]. As it is well known, SCI leads to the release of
massive of glutamate [81]. And excitotoxicity of glutamate
was widely studied and showed signiﬁcant involvement in
secondary damage [81]. In 1999, Vezzani et al. reported that
glutamate could induce IL-1 synthesis [82]. These studies
suggest that TLRs may be associated with not only inﬂam-
mation but also many other mechanisms involved in spinal
cord secondary injury.
In conclusion, the present study showed with rat com-
pression SCI models that traumatic injury that caused tissue
damages may trigger TLRs signals, and TLRs MyD88-
dependent pathway may play crucial roles in the secondary
injury. Inhibition of the TLRs MyD88-dependent pathway at
early time after spinal cord injury could protect the spinal
cord from inﬂammation and apoptosis and promote the
functional recovery.
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